News - Archive
In memory of Prof. Jose Mariano Gago
- Details
It is with great sadness we learned of the death of Prof. Jose Mariano Gago on April 17, 2015. He will be very much missed.
Biomed Alliance General Annual Meeting November 2014, Brussels
- Details
Programme
Agenda
List of attendees
Presentations
H2020 the current status
Ruxandra Draghia-Akli – Director of the Health Directorate, DG
Research & Innovation
The European Research Council and biomedical & health research
Eva Kondorosi – ERC Scientific Council Member
Science Europe and biomedical sciences driven policies
Nathalie Kayadjanian – Senior Scientific Officer, Science
Europe
European policy and biomedical research
Teresa Riera Madurell – Advisor, BioMed Alliance
Cancer Core Europe: A first step towards a virtual cancer institute in Europe?
- Details
During the last decades, we have witnessed remarkable advances in basic cancer research as well as related disciplines. These developments together with the advent of novel and powerful technologies have provided new opportunities for delineating innovative clinical research strategies.
Shaping science policy in Europe
- Details
Molecular Oncology: Shaping science policy in Europe
New Scientific Panel for Health to be established under HORIZON 2020
- Details
A leap forward for health research in Europe: top scientists to have more say in EU-funded research agenda
BioMed Alliance General Annual Meeting, November 2013, Brussels
- Details
Presentations:
Implementing the European Council for health research (EUCHR): The Scientific steering board
- Details
The Alliance for Biomedical Research in Europe (BioMed Alliance) has been long advocating for a strategic instrument – the ‘European Council for Health Research (EuCHR)’ – to foster innovation in Europe by using contemporary evidence to bridge the gap between health research and policy for the benefit of society.
A scientific-led strategic body that can steer health research and innovation across Horizon 2020 (H2020) lies at the core of the EuCHR concept. Indeed, to implement the concept of the EuCHR it would be necessary to establish a Scientific Steering Board (SSB).
EMRC Statement - Why we need a new strategy for health research in Europe
- Details
European Medical Research Councils - along with learned societies and patients’ groups – make the case for changes to the Horizon 2020 proposals – calling for increased spending on biomedical science and the creation of a European Clinical Research Fund.
http://www.sciencebusiness.net/news/75940/Why-we-need-a-new-strategy-for-health-research-in-Europe
BioMed Alliance General Annual Meeting, November 2012, Brussels
- Details
Programme
List of attendees
GA agenda
GA minutes
Letter from Teresa Riera
Presentations:
FEBS News article on the alliance for Biomedical research in Europe
- Details
Scientific activity has always been international. More than a third of all scientific publications in the EU have authors from at least two different countries.
The Future of Health Research and Innovation in Europe: The need for Strategic Action
- Details
Download the report of the conference.
The Future of Health Research and Innovation Europe (23 May): Final programme
Presentations:
Françoise Meunier European Organisation for the Research and Treatment of Cancer
Michel Goldman Innovative Medicines Initiative
Jeremy Haigh European Federation of Pharmaceutical Industries and Associations
Ruxandra Draghia-Akli European Commission, DG RTD
Roger Bouillon European Medical Research Councils
Liselotte Højgaard Copenhagen Research Forum
Valentin Fuster BioMed Alliance, EuCHR Core Working Group
Geoffrey Laurent University College London
European Council for Health Research Concept Paper
- Details
In health, research is the key to identifying causes of disease and developing strategies for health promotion and prevention, as well as diagnosis and treatment. It helps save lives.
New treatments, drugs and technologies are a result of many years of study, trials, promise and investment. But in this golden age of genomics and biomedical research, why aren’t many promising discoveries benefiting patients as rapidly as expected? Why are Europe’s innovators increasingly relocating outside Europe? And how are EU Member States going to tackle the challenge of ever increasing healthcare costs given the demographic trends of an ageing population, in a time of economic gloom?
EuCHR - Illustrating its major impact on European Health Research
- Details
In order to provide further insight into the need for a EuCHR and how it can truly benefit both the economy of Europe as well as citizens, examples of its positive impact are outlined below. The case studies outlined are attempting to provide over-arching examples of what can be achieved, and are not restricted to one discipline or disease but rather have been provided to raise awareness of how the EuCHR can support a multitude of diseases and biomedical research areas. There are of course many other examples that can be provided, but due to space and time restrictions, are not indicated below.
EuCHR - Illustrating its major impact on European Health Research
BioMed Alliance EuCHR Core Working Group
- Details
This Concept Paper has been initiated by a group of multidisciplinary, multi‐professional ‘opinion‐leaders’, nominated by the member societies of the Alliance for Biomedical Research in Europe (BioMed Alliance), along with the BioMed Alliance Executive Committee.
BioMed Alliance General Annual Meeting, November 2011, Brussels
- Details
Programme
Participants
Presentations
- To view the Webcasts please follow the links below.-
Prof. Maria Calvalho: Strengthening European Research - the views of the Parliament
Dr. Donald Dingwell: ERC and future plans
Dr. Alain Vanvossel : Plans for strengthening European Biomedical Research
Dr. Tomas Zima: Federation of European Biochemical Societies
Ms. Monika Hierath: European Institute for Biomedical Imaging Research
General Assembly
Position Paper Horizon 2020: Addressing the Health Challenge
- Details
To sustain a healthy and productive European population, the Alliance for Biomedical
Research in Europe calls upon the European Institutions to:
- Boost biomedical and clinical research with appropriate resourcing at the EU level
- Implement structured consultation with the biomedical researchers to ensure proper targeting and priority-setting for funding
- Create an interconnected and coherent EU biomedical research programme, including the creation of a “European Council for Health Research”
- Enhance international cooperation and global initiatives
A new Alliance: biomedical societies in Europe unite to support research
- Details
After years of stagnant finances for research, moves are under way to increase research funds in Europe
Health care for its ageing population has been recognized by the European Union as one of the great challenges ahead,1 calling for innovative approaches in prevention, early disease detection, and treatment. Yet, the very foundations of innovation in health care, i.e. biomedical research and researchers, are under threat. European funding for biomedical research is insufficient, fragmented, and not competitive.